Shoulder joint disease
Conditions
Interventions
Group I :Ultrasound-guided intraplanar insertion, 0.375% ropivacaine 20ml was injected into ITM fascia plane
Group B:Ultrasound-guided intraplanar injection, 0.375% ropivacaine 20ml was injected into intermuscular sulcus brachial plexus nerve
Sponsors
Jinjiang Municipal Hospital(Shanghai Sixth People's Hospital Fujian Hospital)
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: ?American Society of Anesthesiologists(ASA):?~? ?Arthroscopic shoulder surgery was planned ?Age 18-65 years old ?BMI: 18-30 kg/m2
Exclusion criteria
Exclusion criteria: ?Pregnant, psychosis or unable to cooperate ?The operating area is infected ?Anaesthetic allergy ?COPD or with other respiratory diseases, Coagulopathy or with severe systemic disease ?Contralateral phrenic nerve palsy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nerve block effect;Hemodynamics;Opioid dosage; | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual Analogue Scale(VAS);Muscle strength of affected limb;Postoperative quality of recovery score, QoR-15; | — |
Countries
China
Contacts
Public ContactLin Jianshui
Jinjiang Municipal Hospital(Shanghai Sixth People's Hospital Fujian Hospital)
Outcome results
None listed